Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone Monotherapy for Major Depressive Disorder
NCT00555997Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ziprasidone in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started Mar 2008; status: completed.
02
Drugs
ziprasidone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00555997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555997.